Literature DB >> 20556828

Plexiform angiomyxoid myofibroblastic tumor of the stomach.

Yoshihisa Takahashi1, Masako Suzuki, Toshio Fukusato.   

Abstract

Plexiform angiomyxoid myofibroblastic tumor of the stomach is a unique mesenchymal tumor that we first described in 2007. The tumor is very rare, and to date, only 18 cases confirmed by immunohistochemistry have been reported in the literature. The patients' ages ranged from 7 to 75 years (mean, 43 years), and the male-to-female ratio was approximately 1:1. Representative clinical symptoms are ulceration, associated upper gastrointestinal bleeding (hematemesis), and anemia. The tumors are located at the antrum in all cases, and grossly, the tumor is whitish to brownish or reddish, and forms a lobulated submucosal or transmural mass. Microscopically, the tumor is characterized by a plexiform growth pattern, the proliferation of cytologically bland spindle cells, and a myxoid stroma that is rich in small vessels and positive for Alcian blue stain. Immunohistochemically, the tumor cells are positive for alpha-smooth muscle actin and negative for KIT and CD34. Differential diagnoses include gastrointestinal stromal tumor and other mesenchymal tumors of the gastrointestinal tract. Some authors proposed that this tumor should be designated as "plexiform fibromyxoma", but this designation might cause confusion. The tumor is probably benign and thus far, neither recurrence nor metastasis has been reported.

Entities:  

Mesh:

Year:  2010        PMID: 20556828      PMCID: PMC2887578          DOI: 10.3748/wjg.v16.i23.2835

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  23 in total

1.  Expression of the intermediate filament nestin in gastrointestinal stromal tumors and interstitial cells of Cajal.

Authors:  T Tsujimura; C Makiishi-Shimobayashi; J Lundkvist; U Lendahl; K Nakasho; A Sugihara; T Iwasaki; M Mano; N Yamada; K Yamashita; A Toyosaka; N Terada
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

2.  Inflammatory myofibroblastic tumor (plasma cell granuloma). Clinicopathologic study of 20 cases with immunohistochemical and ultrastructural observations.

Authors:  G Pettinato; J C Manivel; N De Rosa; L P Dehner
Journal:  Am J Clin Pathol       Date:  1990-11       Impact factor: 2.493

3.  KIT activation is a ubiquitous feature of gastrointestinal stromal tumors.

Authors:  B P Rubin; S Singer; C Tsao; A Duensing; M L Lux; R Ruiz; M K Hibbard; C J Chen; S Xiao; D A Tuveson; G D Demetri; C D Fletcher; J A Fletcher
Journal:  Cancer Res       Date:  2001-11-15       Impact factor: 12.701

4.  Gain-of-function mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumors.

Authors:  Seiichi Hirota; Akiko Ohashi; Toshirou Nishida; Koji Isozaki; Kazuo Kinoshita; Yasuhisa Shinomura; Yukihiko Kitamura
Journal:  Gastroenterology       Date:  2003-09       Impact factor: 22.682

5.  Gastric fibromyxoma, a distinct entity of pure fibroblastic tumor--an ultrastructural study.

Authors:  Masaharu Fukunaga
Journal:  APMIS       Date:  2004 Apr-May       Impact factor: 3.205

6.  Plexiform fibromyxoma: a distinctive benign gastric antral neoplasm not to be confused with a myxoid GIST.

Authors:  Markku Miettinen; Hala R Makhlouf; Leslie H Sobin; Jerzy Lasota
Journal:  Am J Surg Pathol       Date:  2009-11       Impact factor: 6.394

7.  Ultrastructure of gastric myxofibroma with intracytoplasmic collagen.

Authors:  M T Hull; J E Jesseph
Journal:  Ultrastruct Pathol       Date:  1982 Jan-Mar       Impact factor: 1.094

8.  Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors.

Authors:  George D Demetri; Margaret von Mehren; Charles D Blanke; Annick D Van den Abbeele; Burton Eisenberg; Peter J Roberts; Michael C Heinrich; David A Tuveson; Samuel Singer; Milos Janicek; Jonathan A Fletcher; Stuart G Silverman; Sandra L Silberman; Renaud Capdeville; Beate Kiese; Bin Peng; Sasa Dimitrijevic; Brian J Druker; Christopher Corless; Christopher D M Fletcher; Heikki Joensuu
Journal:  N Engl J Med       Date:  2002-08-15       Impact factor: 91.245

9.  Gastrointestinal stromal tumors--value of CD34 antigen in their identification and separation from true leiomyomas and schwannomas.

Authors:  M Miettinen; M Virolainen
Journal:  Am J Surg Pathol       Date:  1995-02       Impact factor: 6.394

10.  PDGFRA activating mutations in gastrointestinal stromal tumors.

Authors:  Michael C Heinrich; Christopher L Corless; Anette Duensing; Laura McGreevey; Chang-Jie Chen; Nora Joseph; Samuel Singer; Diana J Griffith; Andrea Haley; Ajia Town; George D Demetri; Christopher D M Fletcher; Jonathan A Fletcher
Journal:  Science       Date:  2003-01-09       Impact factor: 47.728

View more
  25 in total

1.  Plexiform angiomyxoid myofibroblastic tumour of the duodenum: a rare entity.

Authors:  Niladri Banerjee; Shahana Gupta; Suvashis Dash; Shibajyoti Ghosh
Journal:  BMJ Case Rep       Date:  2015-07-27

2.  Plexiform angiomyxoid myofibroblastic tumor of the stomach: a case report.

Authors:  Aeri Kim; Young Kyung Bae; Hyeong Chan Shin; Joon Hyuk Choi
Journal:  J Korean Med Sci       Date:  2011-10-27       Impact factor: 2.153

3.  Plexiform fibromyxoma with cotyledon-like serosal growth: A case report of a rare gastric tumor and review of the literature.

Authors:  Joshua Robert Kane; Natasha Lewis; Rebecca Lin; Celina Villa; Alexandra Larson; Jeffrey D Wayne; Anjana V Yeldandi; William B Laskin
Journal:  Oncol Lett       Date:  2016-02-04       Impact factor: 2.967

4.  Recurrent MALAT1-GLI1 oncogenic fusion and GLI1 up-regulation define a subset of plexiform fibromyxoma.

Authors:  Lien Spans; Christopher Dm Fletcher; Cristina R Antonescu; Alexandre Rouquette; Jean-Michel Coindre; Raf Sciot; Maria Debiec-Rychter
Journal:  J Pathol       Date:  2016-05-20       Impact factor: 7.996

5.  [Plexiform angiomyxoid myofibroblastic tumour of the stomach].

Authors:  T Schulz; J Drgac; C Chmelar; T Höhler; A Agaimy; M Vieth
Journal:  Pathologe       Date:  2012-02       Impact factor: 1.011

6.  Gastric plexiform fibromyxoma resected by endoscopic submucosal dissection after observation of chronological changes: A case report.

Authors:  Fumiaki Kawara; Shinwa Tanaka; Takashi Yamasaki; Yoshinori Morita; Yoshiko Ohara; Yoshihiro Okabe; Namiko Hoshi; Takashi Toyonaga; Eiji Umegaki; Hiroshi Yokozaki; Takanori Hirose; Takeshi Azuma
Journal:  World J Gastrointest Oncol       Date:  2017-06-15

7.  Presence of smooth muscle cell differentiation in plexiform angiomyxoid myofibroblastic tumor of the stomach: a case report.

Authors:  Peifeng Li; Shaolong Yang; Cuicui Wang; Yamin Li; Ming Geng
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

8.  Plexiform angiomyxoid myofibroblastic tumor (PAMT) of the stomach. A case report focusing on its characteristic growth pattern.

Authors:  Masako Ikemura; Eriko Maeda; Fumihiko Hatao; Susumu Aikou; Yasuyuki Seto; Masashi Fukayama
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

9.  Plexiform Angiomyxoid Myofibroblastic Tumor (PAMT) of Stomach with Synchronous Bilateral Cystic Ovarian Neoplasms, a Rare Case Presentation.

Authors:  Jagannath Dattatreya Dixit; Shiraz Ahamed Sharief; Manish Kumar Goyal; Sameeha Khan; Lubna Kauser
Journal:  Indian J Surg Oncol       Date:  2015-08-26

Review 10.  Beyond the GIST: mesenchymal tumors of the stomach.

Authors:  Hyunseon C Kang; Christine O Menias; Ayman H Gaballah; Stuti Shroff; Melissa W Taggart; Naveen Garg; Khaled M Elsayes
Journal:  Radiographics       Date:  2013-10       Impact factor: 5.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.